January 30, 2019
Long-term Extension From RCC Phase II (11515)
Read More
January 30, 2019
Long-term Extension From RCC Phase II (11515)
Read More
January 30, 2019
Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell&h...
Read More
January 30, 2019
Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell&h...
Read More
January 30, 2019
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Read More
January 30, 2019
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Read More
January 30, 2019
Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell&he...
Read More
January 30, 2019
RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With…
Read More
January 30, 2019
BAY43-9006 Phase II Study for Renal Cell Carcinoma
Read More
January 30, 2019
Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subje...
Read More
January 30, 2019
Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metasta...
Read More
January 30, 2019
A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With&h...
Read More
Load More